Biotech grants in Spain

Scheduled

Funds a €3M coordination action that benchmarks emerging industrial bio-based systems for cleaner, circular and more competitive European value chains.

Scheduled

Funds three €4M research projects that replace hazardous biocidal actives with safer bio-based substances for wood and mosquito control.

Scheduled

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

Scheduled

Funds two €7–8M innovation projects that move food-system microbiome products from validated testing toward reliable EU-market scale-up.

Scheduled

Funds two projects to use livestock microbiomes for healthier animals, lower antimicrobial use and safer, more sustainable One Health systems.

Between cycles

Funds late stage deep tech start ups and small businesses with combined non dilutive and growth support across technology fields.

Between cycles

Invests in scale-up ventures in digital, clean technology, and biotechnology through equity to accelerate commercialization pathways.

Between cycles

Funds researchers 5 to 15 years past their PhD who are building an independent research team in Europe through an ERC Consolidator Grant.

Between cycles

Funds innovative SME-led international R&D consortia through the Eurostars Call 12 grant process.

Between cycles

Funds advanced innovation projects advancing robotics and physical AI deep-tech initiatives toward scalable outcomes.

Between cycles

Supports ARPA inspired high risk demand driven pilots translating new approach methods into practical deep tech practice.

Between cycles

Funds bottom-up research for breakthrough deep-tech, any field of science.

Between cycles

Invests in European deep-tech scale-up ventures with momentum needing capital for commercial expansion.

Between cycles

Supports EIC beneficiaries' participation in major trade fairs across the EU, MENA and the US.

Between cycles

Funds early-stage deep tech startups developing solutions at TRL 4-5 in collaboration with industry partners through a 4-month co-creation programme.

Between cycles

Runs research teams and institutions for EIT Health Catapult Edition in biotechnology, medical technology, and artificial intelligence.

Between cycles

Supports international consortia so small companies can turn joint innovation into export-ready products.

Between cycles

Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.

Between cycles

Funds for-profit deep-tech companies from any NATO member nation that are developing dual-use solutions to critical defence and security challenges, through competitive annual and dynamic challenge calls.

Between cycles

Runs themed competitions in which teams compete over several stages to solve one defined technical problem.

Between cycles

Supports early-stage German innovators through a pilot challenge route with mentoring and development funding.

Closed

Pays up to 25 small consortia EUR 200,000 each to test the commercial exploitation potential of results that already came out of earlier Horizon Europe or Horizon 2020 Cluster 4 projects.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Pays deep-tech start-ups, SMEs and research organisations a €300,000 lump sum in Stage 1, then up to €2.5 million in Stage 2, to push high-risk breakthrough innovations that lack commercial uptake toward real-world, demand-tested deployment.